Global food ingredient
provider Chr. Hansen has been acquired by European private equity firm PAI
Partners for 1.1 billion euros. PAI intends to use Chr. Hansen as a
platform for growth, which could happen through continued expansion of
geographic market coverage and investment in capacity and R&D, as well
as potential add-on acquisitions. Chr. Hansen’s new chief executive
officer is Lars Frederiksen, former executive vice president of business
operations. The headquarters will remain in Denmark; the company’s
North American base is Milwaukee. North American CEO David Carpenter sees
the deal as providing an opportunity “to develop value-added products
and systems to meet our local customer needs.”
In other Chr. Hansen news,
the company recently opened its new Middle East and Africa headquarters in
Dubai, United Arab Emirates, and offices in Bogota, Colombia. The South
American move will enable the ingredients company to serve its increasing
number of customers in Colombia, Ecuador and Venezuela. Last year, Chr.
Hansen experienced 20 percent business growth in Brazil and Argentina
combined. The company expanded its Quilmes plant near Buenos Aires, adding
space for laboratories, offices and a pilot plant.
Main Street Ingredients has
announced its outstanding audit results from the American Institute of
Baking and the National Food Processor Association. Main Street’s
quality and safety programs have been audited and evaluated annually by
AIB, and this year the ingredients maker also used the NFPA to conduct
independent audits of its manufacturing facilities. For the seventh
consecutive year, La Crosse, Wis.-based Main Street earned a superior
Health & Food Technologies has launched a new logo for its
CoroWise Naturally Sourced Cholesterol Reducer brand of plant sterols,
communicating the product’s consumer benefits. The logo breathes new
life into the CoroWise branding strategy. Products currently using CoroWise
include Minute Maid Premium Heart Wise Orange Juice, Yoplait Healthy Heart
Yogurt and Rice Dream Heartwise Rice Drink.
Food Ingredients was named by France-based Ferco Nutraceutique as the
exclusive distributor for its Grap`Active product line in North America and
Asia. Degussa will market, under the trade name Grap`Active, various types
of grape seed and grape skin extracts into the functional food and health
supplement market. Ferco Nutraceutique is specialized in the extraction of
polyphenol and proanthocyanidine rich fractions of high quality grapes from
French vineyards. In other Degussa news, the ingredients maker started
production of texturizing blends in its newly built Shanghai, China, plant.
Interbake Foods plans
to consolidate its wafer production capacity from two older baking
operations in Elizabeth, N.J., and Richmond, Va., to a new facility in
Front Royal, Va. The existing facilities will be closed over the next 18
months and the new plant is expected to be running by late summer.
Columbus, Ohio-based Interbake Foods is a division of Weston Foods Inc.,
whose parent company is George Weston Ltd., Toronto.
Lipid Nutrition has
launched a new Web site, www.lipidnutrition.com
, which incorporates the new
company image and logo. The Web site offers more comprehensive information
on the company’s lipid-based products. The company, based in
Channahon, Ill., is a division of Loders Croklaan.
FMC BioPolymer has
announced it will raise pricing of its food and pharmaceutical
cellulosic-based products by an average of 5 to 7 percent depending on the
product line. The Philadelphia-based company attributes this to a rise in
costs in raw materials, energy and packaging.
Brooklyn, N.Y.-based Virginia
Dare plans to release the results of its first flavor preference
survey at July’s Institute of Food Technologists’ show in New
Orleans. The company is researching consumer flavor preferences to provide
unique insights to its customers. Survey results will be revealed at
Virginia Dare booth 2731 at the IFT Food Expo.
Correction: The Dairylogue column “Did They Know?” in the
Dairy R&D section of the March 2005 issue should have referred to
“… high levels of the insulin-like Growth Factor-1 (IGF-1)